QC
TXG icon

Quantedge Capital’s 10x Genomics TXG Stock Holding History

Quantedge Capital’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.1M Sell
80,953
-335,600
-81% -$8.79M 2.35% 14
2026
Q1 		$8.84M Buy
416,553
+212,600
+104% +$4.25M 4.84% 4
2025
Q4 		$3.33M Buy
+203,953
New +$3.08M 1.59% 17

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Quantedge Capital's TXG Position: Q2 2026 in Review

Quantedge Capital reduced its 10x Genomics (TXG) stake by 81% in Q2 2026, selling an estimated $8.79M and leaving 80,953 shares worth $3.1M. The position accounts for 2.35% of the portfolio, ranked #14.

Quantedge Capital first reported a position in TXG in Q4 2025 and has held it in 3 quarters since. The position peaked at $8.84M in Q1 2026. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Quantedge Capital held 80,953 shares of 10x Genomics worth $3.1M as of Q2 2026.
  • Quantedge Capital sold 335,600 10x Genomics shares in Q2 2026, an estimated $8.79M.
  • 10x Genomics made up 2.35% of Quantedge Capital's portfolio in Q2 2026, its #14 holding.
  • Quantedge Capital first reported a position in 10x Genomics in Q4 2025 and has held it in 3 quarters since.
  • Quantedge Capital's 10x Genomics position peaked at $8.84M in Q1 2026.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Quantedge Capital's 13F filing for Q2 2026, filed 6 Aug 2026.